Pamela Wright
Nurse Practitioner · Knoxville, TNNPI 1376538892
Payments from drug & device makers
Across 116 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$637
- Genentech USA, Inc.$499
- Amgen$231
- Sanofi$229
- Regeneron Healthcare Solutions, Inc.$199
- GSK$160
- plus $592 from 11 others
What the payments were for
- Food & beverage$2,32391%
- Education$2239%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $637 |
| Genentech USA, Inc. | 23 | $499 |
| Amgen | 12 | $231 |
| Sanofi | 10 | $229 |
| Regeneron Healthcare Solutions, Inc. | 6 | $199 |
| GSK | 9 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $141 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Boehringer Ingelheim | 6 | $92 |
| Pharming Healthcare, Inc. | 2 | $56 |
| Novartis | 2 | $47 |
| AbbVie | 2 | $39 |
| CSL Behring | 1 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Kaleo, Inc. | 1 | $24 |
| Biocryst US Sales Co., LLC | 1 | $19 |
| Hospira, Inc. | 1 | $12 |
How this compares
$2,546 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 22 | $76,570 |
| Azelastine Hcl | 87 | $3,445 |
| Fluticasone Propionate | 165 | $2,807 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,034 |
| Montelukast Sodium | 50 | $666 |
| Methylprednisolone | 13 | $98 |
| Famotidine | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Knoxville
- Karen RodenKnoxville$265K
- Erica HembreeKnoxville$125K
- Robin LovedayKnoxville$56K
- Tiffany SteelmanKnoxville$21K
- Jennifer BerryKnoxville$19K
- Erica HillKnoxville$13K
- Amy HatcherMurfreesboro$1.1M
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Brooke FaughtNashville$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.